Vaxxinity Inc (VAXX) - News Archive

Showing 3 of 3 results.

Vaxxinity's Strategic Vision Paves the Way for Shareholder Success

In a recent press release, Vaxxinity, Inc. showcased its commitment to innovation and advancement in the pharmaceutical industry. The company, pioneering the development of a groundbreaking class of medicines, issued a...

Apr 19, 2024 • Major Pharmaceutical Preparations Industry Stock Market Announcement

Vaxxinity's Breakthrough Immunotherapy, UB-312, Shows Promise in Reducing Pathological Alpha-Synuclein in Parkinson's Patients

Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson s Disease at AD/PD 2024Parkinson s disease is a debilitating neurodegenerative disorder that affects millions of people world...

Mar 7, 2024 • Major Pharmaceutical Preparations Industry Clinical Study

Vaxxinity's Promising Cholesterol Vaccine Lowers LDL-C: Promising Preclinical Data Paves the Way to Uphold Cardiovascular Disease Management

Vaxxinity s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Promising Preclinical Data PublishedPreclinical data published in the Journal of Lipid Research has revealed that Vaxxinity Inc s cholesterol vaccine...

Feb 15, 2024 • Major Pharmaceutical Preparations Industry Product Service News